BV / Quality
Pharmaceutical-grade peptides, lot-traced end-to-end.
Every batch is tested by HPLC, identity-confirmed by mass spectrometry, endotoxin-screened against USP <85>, and released under cGMP-aligned procedures. COAs publish to your portal — not into a sales-rep inbox.
Identity & purity
HPLC + mass spec on every batch.
Reverse-phase HPLC is run on every lot and reported as a percentage with two decimals alongside the mass-spectrometry confirmation. We publish the actual numbers — not a rounded ≥99% claim with no detail behind it.
- HPLC purity
- Reported per lot
- Mass spec
- Identity confirmation
- Endotoxin
- USP <85> per lot
- COA retention
- 7 years
cGMP-aligned production
Manufacturing documentation your inspector expects.
API production runs against documented procedures: lot release checklist, in-process quality controls, USP-aligned identity and purity testing, residual-solvent screens, and microbial bioburden per batch. Manufacturing process documentation and stability data are accessible per SKU on the customer portal.
The paper trail follows the bottle. When a 503B accreditor or pharmacy board asks where the API came from, you can point them at a clean document trail without an email back-and-forth.
503A & 503B documentation
Aligned with compounding pharmacy needs.
Compounding pharmacies operating under 503A and outsourcing facilities under 503B both face documentation expectations from state boards, FDA, and third-party accreditors. Bioveris API documentation is structured to slot into those records:
- Per-lot COAs with HPLC, mass-spec, endotoxin, residual solvent, and microbial-bioburden results
- Supplier qualification packet with quality agreement template, audit history, and change-notification protocol
- USP-aligned identity testing on every batch — references the specific USP monograph or in-house procedure where USP coverage doesn't exist
- Lot release statement signed by quality-unit personnel; retained for 7 years
Lot traceability
The vial label, the order record, and the COA all carry the same lot number.
When you receive a Bioveris order, the lot stamped on the vial maps back to a batch record in your portal. Pull up any past order and the same lot, COA, and shipping documentation are one click away — for every dose you've ever administered.
That same trail flows into your records, so when a regulator asks how you sourced an ingredient, the answer is on a single screen.
Cold-chain handling
Packed, tendered, and tracked end-to-end.
Vials ship from a temperature-controlled facility in the United States, packaged with phase-change materials sized to the destination ZIP. Tracking numbers post automatically to the order detail page; deliveries to restricted states are blocked at checkout, not discovered in transit.
Restricted-substance allowlist
State-by-state product flags surface at checkout.
State pharmacy and medical board rules around specific peptide compounds change frequently. Bioveris maintains a live allowlist per destination state, blocking any restricted compound at cart-add rather than at delivery. Practitioners operating under a research authorization or other exception can contact compliance for a per-order review.
Ready to read a real COA?
Apply for access. Once your license is verified you can browse the full catalog with the actual lot data behind each SKU.